Media about us

• A new training center will be established in NovaMedica Innotech

  12 February 2018 GMP News

  

  NovaMedica, a Russian pharmaceutical company and the investment project of RUSNANO, has announced the collaboration in the area of knowledge and technology transfer between NovaMedica Innotech, an R&D center, and Evonik, a German company and a leader in the global market of excipients for pharmaceutical industry.

• Syndax entered a clinicial trial collaboration with AstraZeneca

  02 February 2018 GMP News

  

  Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced a new clinical collaboration with AstraZeneca to evaluate the safety and efficacy of AstraZeneca’s durvalumab.

• Russia grants Hermes GMP certification at German and Austrian plants

  22 January 2018 Dan Stanton / In-Pharma Technologist.com

  

  Since 2011, Russian policy has favoured local production in e􀃗orts to reduce reliance on pharmaceutical imports. Vladimir Putin’s ‘Pharma 2020’ policy pushes for as much 90% of drugs consumed in Russia to be made domestically by 2020. Such policies have led multinationals to tap the market through collaborations with domestic drugmakers. Pfizer, for example, teamed with Russian pharma firm NovaMedica last May to build an aseptic manufacturing plant in.

• Start Up Spotlight: OCON Medical Bets On A New 3D Copper Contraceptive Device

  19 January 2018 Catherine Longworth / MedTech Insight

  

  Israeli start up OCON Medical is blazing a trail in the field of women's health with a new hormone-free contraceptive device. The company's IUB – intrauterine ball consists of copper pearls that prevent pregnancy locally within the uterus for five years.

• NovaMedica Innotech R&D center meets Russian GMP standards

  28 December 2017 GMP News

  

  NovaMedica, a Russian pharmaceutical company and investment project of RUSNANO, announced that it received the conclusion of the Russian Ministry of Industry and Trade on the compliance of the production site of NovaMedica Innotech R&D center, a subsidiary of NovaMedica, with the Russian Good Manufacturing Practice (GMP) standards.

• Authorities approve the application of NovaMedica for a new production facility

  26 December 2017 GMP News

  

  NovaMedica, a Russian pharmaceutical company and investment project of RUSNANO, announced that it received the approval of the Inter-Agency Commission for conclusion of Special Investment Contract (SPIC) under the investment project aimed at establishing a pharmaceutical plant for sterile injectable drugs in the Kaluga region.

• Contract pharmaceutical manufacturing sites in Russia are very relevant

  27 November 2017 GMP News

  

  A round table on Contract Manufacturing of Pharmaceutical Products was held on November 22, 2017, at Pharmtech & Ingredients 2017, the 19th international exhibition of equipment, raw materials and technologies for pharmaceutical manufacturing. The event moderator was Alexander Kuzin, the General Director at NovaMedica. 

• Contract R&D market is developing in Russia

  23 October 2017 GMP News

  

  NovaMedica has launched in Moscow its R&D Center for development of new drug products. The Center is going to become attractive R&D site for customized developments and contract manufacturing.

• Russian pharmaceutical map has a new point of convergence

  23 October 2017 GMP News

  

  An interesting international pharmaceutical project has started in Russia. This project is a result of a convergence of interests of Rusnano, Russian state investment corporation, Domain Associates, an American venture capital foundation, and Pfizer, an American pharmaceutical corporation.  

• NovaMedica receives a license for production site at its R&D center

  20 October 2017 GMP News

  

  NovaMedica received a license from the FBI SID & GP for a pilot production site at its R&D center. This was announced by Alexander Kuzin, the General Director of the company.